Key result
Highest uric acid-to-HDL-C ratio linked to ~7.9-fold higher odds of cardiometabolic risk clustering.
Why the study?
Although serum uric acid and HDL-C are individual cardiometabolic risk factors, the combined uric acid-to-HDL-C ratio (UHR) remains under-investigated in the pediatric population.
Does the uric acid to high-density lipoprotein cholesterol ratio (UHR) predict high blood pressure, high triglyceride levels, and cardiometabolic risk factor clustering better than uric acid or HDL-C alone in Taiwanese adolescents?
Cross-Sectional (n=26,658)
Does the uric acid to high-density lipoprotein cholesterol ratio (UHR) predict high blood pressure, high triglyceride levels, and cardiometabolic risk factor clustering better than uric acid or HDL-C alone in Taiwanese adolescents?
The uric acid to HDL-C ratio (UHR) is an accessible, zero-incremental-cost biomarker that outperforms individual uric acid or HDL-C levels in identifying adolescents with high triglycerides and cardiometabolic risk factor clustering.
Answers are grounded in this paper and cite their sources.
UHR may flag cardiometabolic clustering in adolescents; hypothesis-generating and requires prospective validation before clinical use.
Background: Early identification of cardiometabolic risk factors in adolescents is crucial for preventing future cardiovascular diseases. Although serum uric acid (UA) and high-density lipoprotein cholesterol (HDL-C) levels are individual risk factors, their combined index, the UA-to-HDL-C ratio (UHR), remains under-investigated in the pediatric population. Methods: We synthesized findings from a cross-sectional analysis of 26,658 Taiwanese high school students. The diagnostic utility of the UHR for predicting high blood pressure, high triglyceride (TG) levels, and risk factor clustering was evaluated using multivariable logistic regression and receiver operating characteristic (ROC) curve analysis. Results: Subjects in the highest UHR quartile (Q4) exhibited a significantly increased risk of high TG levels (odds ratio [OR] = 11.60) and cardiometabolic risk factor clustering (OR = 7.88). ROC analysis showed excellent diagnostic accuracy (AUC ~0.80), which was superior to UA or HDL-C individually (p < 0.001). Conclusions: The UHR is a reliable and easily accessible biomarker. Integrating the UHR into routine adolescent screening could optimize health resource allocation and improve long-term cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) conducted a cross-sectional in Cardiometabolic risk factor clustering (n=26,658). Uric acid to HDL-C ratio (UHR) highest quartile (Q4) vs. Lowest UHR quartile (Q1) was evaluated on Cardiometabolic risk factor clustering (presence of ≥2 risk factors among high BP, high triglycerides, and elevated fasting glucose) (OR 7.88, 95% CI 4.88-12.71, p=<0.001). Adolescents in the highest uric acid-to-HDL-C ratio quartile (Q4) had higher odds of cardiometabolic risk factor clustering compared to the lowest quartile.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: